<DOC>
	<DOCNO>NCT00412763</DOCNO>
	<brief_summary>The overall objective project ass whether Silymarin therapy shorten illness prevents complication patient acute hepatitis . We specifically compare response acute hepatitis patient treat Silymarin give control preparation vitamin supplement double blind , randomize , placebo-controlled trial .</brief_summary>
	<brief_title>Efficacy Silymarin Acute Hepatitis</brief_title>
	<detailed_description>The study design double-blinded placebo control trial . We compare 4 week course therapy silymarin tablet low-dose vitamin preparation ( placebo ) follow-up total 8 week assess treatment response . Outcomes randomize control trial improvement symptom sign , normalization liver function , time resume normal activity , sense well-being . This protocol follow standard therapeutic care acute hepatitis except patient receive either herbal supplement ( silymarin ) , many patient take anyway , vitamin placebo . Freshly collect serum test anti-HAV IgM , anti-HBc Igm , anti-HBs , HBs Ag , anti-HCV antibody , HCV-RNA , anti-HDV IgM , anti-HEV IgM , CMV EBV alanine aminotransferase ( ALT ) , AST , direct total bilirubin .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Silymarin</mesh_term>
	<criteria>Patients admit fever hospital presenting symptom sign may consistent diagnosis acute hepatitis . Recent ( &lt; 1 month ) history illness . Elevation ALT &gt; 2.5 normal . At least 13 year old . History suggestive severe druginduced acute hepatitis . Children 12 year younger . Pregnant breastfeed woman Suspected hypersensitivity Silymarin vitamin preparation . Evidence advance liver disease e.g . history presence ascitis , bleed esophageal varix , hepatic encephalopathy . Patients critically ill , multisystem failure cancer . Substance abuse IV drug . Any condition , opinion investigator would make patient unsuitable enrollment could interfere patient 's participation completion protocol .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2006</verification_date>
	<keyword>Acute hepatitis</keyword>
	<keyword>Acute viral hepatitis</keyword>
	<keyword>Acute nonviral hepatitis</keyword>
	<keyword>Silymarin</keyword>
	<keyword>Milk Thistle</keyword>
</DOC>